Orange Book Listings For Unapproved Uses May Be OK, Appeals Court Says

Congress should revisit Waxman/Hatch to clarify whether the statute is intended to restrict the scope of patent protection to only approved uses of a drug, U.S. Federal Circuit Judge Richard Linn said